Skip to main content
spacbrain

Semnur Pharmaceuticals

Closed (deSPAC)

Health Care · non-opioid pain management pharmaceuticals

What it is
Pharmaceuticals, Inc
What it’s doing now
Merging with Denali Capital Acquisition Corp. (DECA) — closed (despac).
What you should know
Data is still being assembled for this company — what is shown below is everything we have verified so far.

The business, per its filings

SEC primary

Pharmaceuticals, Inc. Semnur is a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies. Semnur’s product candidate, SP-102 (SEMDEXA ™ ), is the first non-opioid novel gel formulation administered epidurally in development for patients with moderate to severe chronic radicular pain/sciatica. Semnur Pharmaceuticals, Inc. is headquartered in Palo Alto, California.

Source: S-4/A, accession 0001193125-25-178821

What the company says about itself

Web research — not audited
What our web check found

[WEB-INTEL 2026-08-26] 3 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Semnur Pharmaceuticals entered into a binding term sheet with iHolding Group LLP for a proposed $100,000,000 equity investment." [https://www.stocktitan.net/sec-filings/SMNR/8-k-semnur-pharmaceuticals-inc-reports-material-event-546d976678df.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "iHolding is expected to buy newly issued Semnur common shares at $10.00 per share, or about 10,000,000 shares." [https://www.stocktitan.net/sec-filings/SMNR/8-k-semnur-pharmaceuticals-inc-reports-material-event-546d976678df.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The closing of the Business Combination is expected to occur by the end of fourth quarter of 2024 or the first quarter of 2025." [https://finance.yahoo.com/news/semnur-pharmaceuticals-inc-wholly-owned-080000945.html] [WEB-INTEL 2026-08-26] 3 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Semnur Pharmaceuticals entered into a binding term sheet with iHolding Group LLP for a proposed $100,000,000 equity investment." [https://www.stocktitan.net/sec-filings/SMNR/8-k-semnur-pharmaceuticals-inc-reports-material-event-546d976678df.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "iHolding is expected to buy newly issued Semnur common shares at $10.00 per share, or about 10,000,000 shares." [https://www.stocktitan.net/sec-filings/SMNR/8-k-semnur-pharmaceuticals-inc-reports-material-event-546d976678df.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The companies expect proceeds, if the deal closes, to support Semnur’s pipeline, including the ongoing Phase 3 program for SEMDEXA (SP-102), and broader growth initiatives." [https://www.stocktitan.net/sec-filings/SMNR/8-k-semnur-pharmaceuticals-inc-reports-material-event-546d976678df.html]

Source: company web presence · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

Semnur Pharmaceuticals is merging with Denali Capital Acquisition Corp. (DECA) currently marked Closed (deSPAC).

Headline equity value—
PIPE≈ $20M · unsourced

Structure per SEC accession(s) 0001193125-25-335407. How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Semnur Pharmaceuticals going public?

Semnur Pharmaceuticals has an approved merger with the SPAC Denali Capital Acquisition Corp. (DECA). Deal status: Closed (deSPAC).

Does Semnur Pharmaceuticals have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other health care deals